Evidence map›Paper›PMID 40839691›Full record

ArticleJournal of clinical microbiology2025

AveloMask, a novel breath aerosol collection kit for airborne

Patricia Risch, Tobias Broger, Zandile Booi, Katie Tiseo, Harshitha Santhosh Kumar, Jamie van Schalkwyk, Theresa Heinrich, Reto Willi, Stefan M Botha, Peter Sander and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Patricia Risch *Avelo AGSchlieren, Switzerland.ORCID 0000-0003-0223-6685
Tobias Broger *Avelo AGSchlieren, Switzerland.ORCID 0000-0002-7959-1055
Zandile BooiDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Katie TiseoAvelo AGSchlieren, Switzerland.ORCID 0009-0002-3652-6859
Harshitha Santhosh KumarAvelo AGSchlieren, Switzerland.
Jamie van SchalkwykDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Theresa HeinrichBLINK AGJena, Germany.
Reto WilliAvelo AGSchlieren, Switzerland.
Stefan M BothaDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Peter SanderInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-1581-0682
Adithya CattamanchiCenter for Tuberculosis, University of California San Francisco, San Francisco, California, USA.
Stephan HuboldBLINK AGJena, Germany.
Claudia M DenkingerDepartment of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-7216-7067
Grant TheronDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Christina FialováZHAW Zurich University of Applied Sciences, School of Life Sciences and Facility Management, Institute of Chemistry and BiotechnologyWädenswil, Switzerland.
Christian Adlhart *ZHAW Zurich University of Applied Sciences, School of Life Sciences and Facility Management, Institute of Chemistry and BiotechnologyWädenswil, Switzerland.ORCID 0000-0002-4081-221X
Rouxjeane Venter *DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0002-8710-8166

Funding

Innosuisse 60413.1NIH HHS U01AI15208
6 · The paper itself

Abstract

Tuberculosis (TB) remains the world's deadliest infectious disease, with many active cases missed due to challenges in sputum collection. Exhaled breath aerosols (XBA), a major route of

Indexed as

Air MicrobiologyMycobacterium tuberculosisSpecimen HandlingTuberculosis, PulmonaryAdultAerosolsAgedBreath TestsFemaleHumansMaleMiddle AgedPilot ProjectsReal-Time Polymerase Chain ReactionSensitivity and SpecificitySouth AfricaAerosolsaccuracyaerosolbreathdiagnosisface mask samplingnon-sputumPCRtuberculosis

Identifiers

PMID40839691
PMCPMC12421833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.